View all results
No results
News
Events
The industry
arrow_drop_down
Industry overview
Industrial biotech
Swiss Biotech Report
Success Stories
Company directory
Jobs
Networking platforms
Newsletter
Association
arrow_drop_down
Mission and services
Members
Academy
Partners
Team
Media
Add listing
Log in
or
Register
0
Add listing
Debio 1454/M
Product
prev
next
Leave a review
Bookmark
Share
Report
prev
next
Indicaton
GI disorders
Therapeutic indications
Infectious disease
Type of product
Small molecule
Company
Debiopharm International SA
Table
Phase
Discovery
Partnering status
Partnered
Partner
Takeda
You may also be interested in
MV-003 Dysbiosis
Dysbiosis ApyraMed promotes microbiome recovery and selection of beneficial bacteria after antibiotic treatment. This results in powerful control of antibiotic-induced enteric infections and metabolic alterations.
Discovery
MV-001 Clostridioides Difficile
Clostridioides Difficile ApyraVax is suitable for continuous dosing, exploits the already marketed and safe Salmonella Ty21a vaccine strain (Vivotif®) and induces high-affinity secretory IgAs that ensure protection from CDI.
Discovery
TOTIPHARMACEUTICAL
Polypharmacology for all therapeutic aeras using nano-drug delivery systems
Discovery
Cart
×
View all results
No results
Facebook
Twitter
WhatsApp
Telegram
Pinterest
LinkedIn
Tumblr
VKontakte
Mail
Copy link
This site uses cookies:
Find out more.
Accept